Literature DB >> 192671

Role of macrophages in hepatitis induced by Herpes simplex virus types 1 and 2 in mice.

S Mogensen.   

Abstract

A marked difference was found between herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in the induction of hepatic necrotic lesions in mice inoculated intraperitoneally. Although HSV-2 produced many large, progressive liver lesions in 4-week-old BALB/c mice, HSV-1 only occasionally induced a few, self-limiting foci, which eventually healed. This was reflected in the isolation of HSV from the liver and spleen, two organs that are rich in macrophages. Although HSV-1 could be only temporarily isolated, HSV-2 was found in the two organs until the mice died. On the other hand, no such difference was found in the isolation of virus from the brain, which contains no macrophages, and the mice eventually died from encephalitis. This difference in hepatic involvement caused by the two virus types was found to parallel a marked difference in the restriction of HSV-1 and HSV-2 replication by macrophages as measured by an infectious center assay in vitro. HSV-2 produced 17 times as many infectious centers in infected peritoneal macrophage cultures as did HSV-1. Furthermore, the HSV-2 plaques in the cell overlay were large and increasing in size, whereas the HSV-1 plaques were small and showed regression on prolonged incubation. It was shown that this diversity was unique to the macrophage population and not caused by differences in the uptake of virus by macrophages. This model involving two closely related virus types shows the importance of tissue macrophages in the primary host defense against virus infections.

Entities:  

Mesh:

Year:  1977        PMID: 192671      PMCID: PMC421424          DOI: 10.1128/iai.15.3.686-691.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Defense mechanisms against infectious bovine rhinotracheitis virus: inhibition of virus infection by murine macrophages.

Authors:  B T Rouse; L A Babiuk
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Role of macrophages and antibody in resistance of mice against yellow fever virus.

Authors:  B Zisman; E F Wheelock; A C Allison
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

3.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

4.  Macrophages and age-dependent resistance to Herpes simplex virus in mice.

Authors:  M S Hirsch; B Zisman; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

5.  Biological markers for differentiation of herpes-virus strains of oral and genital origin.

Authors:  M E Figueroa; W E Rawls
Journal:  J Gen Virol       Date:  1969-03       Impact factor: 3.891

6.  Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction.

Authors:  J G Stevens; M L Cook
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

7.  Biological conditions influencing the focal necrotic hepatitis test for differentiation between herpes simplex virus types 1 and 2.

Authors:  S C Mogensen
Journal:  Acta Pathol Microbiol Scand B       Date:  1976-06

8.  Interaction of mouse peritoneal macrophages with fixed rabies virus in vivo and in vitro.

Authors:  G S Turner; R Ballard
Journal:  J Gen Virol       Date:  1976-02       Impact factor: 3.891

9.  Role of macrophages in resistance to murine cytomegalovirus.

Authors:  M K Selgrade; J E Osborn
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

10.  Prevention of cell-to-cell spread of herpes simplex virus by leukocytes.

Authors:  D L Lodmell; A Niwa; K Hayashi; A L Notkins
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

View more
  20 in total

1.  Effect of silica on the pathogenic distinction between herpes simplex virus type 1 and 2 hepatitis in mice.

Authors:  S C Mogensen; H K Andersen
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Effect of Mycobacterium tuberculosis BCG infection on the resistance of mice to ectromelia virus infection: participation of interferon in enhanced resistance.

Authors:  T Suenaga; T Okuyama; I Yoshida; M Azuma
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

3.  Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2.

Authors:  S C Mogensen; H K Andersen
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  Macrophages and age-dependent resistance to hepatitis induced by herpes simplex virus type 2 im mice.

Authors:  S C Mogensen
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

Review 5.  Role of macrophages in natural resistance to virus infections.

Authors:  S C Mogensen
Journal:  Microbiol Rev       Date:  1979-03

6.  Kinetics and genetics of herpes simplex virus-induced antibody formation in mice.

Authors:  A Knoblich; J Görtz; V Härle-Grupp; D Falke
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Mechanisms of enhanced resistance of Mycobacterium bovis BCG-treated mice to ectromelia virus infection.

Authors:  T Sakuma; T Suenaga; I Yoshida; M Azuma
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

8.  Different susceptibilities of skin to type 1 and type 2 herpes simplex viruses in newborn rabbits.

Authors:  J O Oh; P Minasi
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

9.  Early interactions of herpes simplex virus with mouse peritoneal macrophages.

Authors:  B Svennerholm; A Vahlne; E Lycke
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

10.  Genetics of macrophage-controlled resistance to hepatitis induced by herpes simplex virus type 2 in mice.

Authors:  S C Mogensen
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.